Gene Synthesis Market Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The
latest report by IMARC Group, titled “Gene Synthesis Market: Industry
Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. The
global gene synthesis market size reached US$ 1.74 Billion in 2022. Looking
forward, IMARC Group expects the market to reach US$ 4.82 Billion by 2028,
exhibiting a growth rate (CAGR) of 17.10% during 2023-2028.
Gene
synthesis is the process of artificially creating specific DNA sequences in the
laboratory. It enables scientists to design and construct custom-made genes
with desired sequences, including modifications, optimizations, or novel
genetic material. This technology has diverse applications in molecular
biology, biotechnology, and genetic engineering, allowing to produce genes used
in recombinant protein expression, gene function studies, synthetic biology
applications, and the development of gene therapies. At present, gene synthesis
is gaining immense traction across the globe as it plays a pivotal role in
advancing genetic research and biotechnological innovations by providing
precise control over DNA sequences for various scientific and medical purposes.
Request
Your Sample Report Now: https://www.imarcgroup.com/gene-synthesis-market/requestsample
Gene
Synthesis Market Trends and Drivers:
The
global gene synthesis market is primarily driven by numerous advancements in
molecular biology and biotechnology that expand the applications of gene
synthesis, including gene editing, synthetic biology, and the development of
biopharmaceuticals. Moreover, the increasing demand for customized DNA sequences
for research, therapeutics, and diagnostics is propelling market growth. Apart
from this, the rising need for automation and cost reduction in gene synthesis
processes that improve the accessibility and affordability of these services
has catalyzed market growth. Additionally, the heightening interest in
precision medicine and personalized therapies has escalated the demand for gene
synthesis in the healthcare sector, thereby fostering market growth.
Furthermore, escalating importance of gene synthesis in the development of
vaccines and diagnostics amid the COVID-19 pandemic is contributing to market
growth
Report
Segmentation:
The
report has segmented the market into the following categories:
Method
Insights:
- Solid-Phase Synthesis
- Chip-Based
Synthesis
- PCR-Based Enzyme
Synthesis
Services
Insights:
- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
Application
Insights:
- Gene and Cell Therapy
Development
- Vaccine Development
- Disease Diagnosis
- Others
End
Use Insights:
- Biotechnology and
Pharmaceutical Companies
- Academic and Government
Research Institutes
- Contract Research
Organizations
Market
Breakup by Region:
- North America (United
States, Canada)
- Asia Pacific (China,
Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany,
France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil,
Mexico, Others)
- Middle East and Africa
Competitive
Landscape with Key Player:
- ATUM
- Boster Biological
Technology
- Eurofins Genomics
- Genewiz Inc. (Azenta
Life Sciences)
- Genscript Biotech Corp.
- Integrated DNA
Technologies Inc.
- Merck KGaA
- OriGene Technologies
Inc.
- ProMab Biotechnologies
Inc.
- ProteoGenix Inc
- Thermo Fisher
Scientific Inc.
- Twist Bioscience
Explore
full report with table of contents: https://www.imarcgroup.com/gene-synthesis-market
If
you need specific information that is not currently within the scope of the
report, we will provide it to you as a part of the customization.
About
Us
IMARC
Group is a leading market research company that offers management strategy and
market research worldwide. We partner with clients in all sectors and regions
to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s
information products include major market, scientific, economic and
technological developments for business leaders in pharmaceutical, industrial,
and high technology organizations. Market forecasts and industry analysis for
biotechnology, advanced materials, pharmaceuticals, food and beverage, travel
and tourism, nanotechnology and novel processing methods are at the top of the
company’s expertise.
Contact
Us
IMARC
Group
Email:
sales@imarcgroup.com
USA:
+1-631-791-1145 | Asia: +91-120-433-0800
Address:
134 N 4th St. Brooklyn, NY 11249, USA
Follow
us on Twitter: @imarcglobal
Comments
Post a Comment